Polynucleotides encoding modified DNA cleavage enzymes and host cells therefor
First Claim
1. A composition, comprising:
- an isolated polynucleotide encoding a variant T7 Endo I polypeptie having endonuclease activity, wherein the variant T7 Endo I polypeptide comprises an amino acid sequence that differs from the amino acid sequence of its parent T7 Endo I polypeptide solely by one or more mutations in a β
-bridge corresponding to amino acids 44-49 of SEQ ID NO;
12.
2 Assignments
0 Petitions
Accused Products
Abstract
Compositions and methods are provided that relate to a modified DNA cleaving enzyme having at least 35% amino acid sequence identity with T7 Endo I. The modified enzyme includes two catalytic centers separated by a β-bridge where the β-bridge contains at least one mutation having an effect of altering enzyme cleavage activity compared to the unmodified enzyme. Activities associated with the modified DNA cleaving enzyme that can be modulated in different reaction conditions include at least one of: (a) non-sequence specific nicking activity; (b) cleaving the second strand of a duplex DNA at a preexisting nick site to produce a linear duplex with a single strand overhang; (c) non-sequence specific DNA cleavage; (d) cleaving DNA flanking a mismatch; and (e) cleavage at a cruciform structure in a DNA duplex.
53 Citations
4 Claims
-
1. A composition, comprising:
- an isolated polynucleotide encoding a variant T7 Endo I polypeptie having endonuclease activity, wherein the variant T7 Endo I polypeptide comprises an amino acid sequence that differs from the amino acid sequence of its parent T7 Endo I polypeptide solely by one or more mutations in a β
-bridge corresponding to amino acids 44-49 of SEQ ID NO;
12.
- an isolated polynucleotide encoding a variant T7 Endo I polypeptie having endonuclease activity, wherein the variant T7 Endo I polypeptide comprises an amino acid sequence that differs from the amino acid sequence of its parent T7 Endo I polypeptide solely by one or more mutations in a β
-
2. A vector comprising a polynucleotide encoding a variant T7 Endo I polypeptide having endonuclease activity, wherein the variant T7 Endo I polypeptide comprises an amino acid sequence that differs from the amino acid sequence of its parent T7 Endo I polypeptide solely by one or more mutations in a β
- -bridge corresponding to amino acids 44-49 of SEQ ID NO;
12.
- -bridge corresponding to amino acids 44-49 of SEQ ID NO;
-
3. A host cell containing a vector comprising a polynucleotide encoding a variant T7 Endo I polypeptide having endonuclease activity, wherein the variant T7 Endo I polypeptide comprises an amino acid sequence that differs from the amino acid sequence of its parent T7 Endo I polypeptide solely by one or more mutations in a β
- -bridge corresponding to amino acids 44-49 of SEQ ID NO;
12.
- -bridge corresponding to amino acids 44-49 of SEQ ID NO;
-
4. A kit comprising in one or more containers a composition comprising a polynucleotide encoding a variant T7 Endo I polypeptide having endonuclease activity, wherein the variant T7 Endo I polypeptide comprises an amino acid sequence that differs from the amino acid sequence of its parent T7 Endo I polypeptide solely by one or more mutations in a β
- -bridge corresponding to amino acids 44-49 of SEQ ID NO;
12.
- -bridge corresponding to amino acids 44-49 of SEQ ID NO;
Specification